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Up-regulation of Ca2+ entry through Ca2+ channels by high rates of beating is involved in the frequency-dependent
regulation of contractility: this process is crucial in adaptation to exercise and stress and is universally known as
force-frequency relation (FFR). Disturbances in calcium handling play a central role in the disturbed contractile
function in myocardial failure. Measurements of twitch tension in isolated left-ventricular strips from explanted
cardiomyopathic hearts compared with non-failing hearts show flat or biphasic FFR, while it is up-sloping in normal
hearts. Starting in 2003 we introduced the FFR measurement in the stress echo lab using the end-systolic pressure
(ESP)/End-systolic volume index (ESVi) ratio (the Suga index) at increasing heart rates. We studied a total of 2,031
patients reported in peer-reviewed journals: 483 during exercise, 34 with pacing, 850 with dobutamine and 664
during dipyridamole stress echo. We demonstrated the feasibility of FFR in the stress echo lab, the clinical
usefulness of FFR for diagnosing latent contractile dysfunction in apparently normal hearts, and residual contractile
reserve in dilated idiopathic and ischemic cardiomyopathy. In 400 patients with left ventricular dysfunction (ejection
fraction 30 ± 9%) with negative stress echocardiography results, event-free survival was higher (p < 0.001) in patients
with ΔESPVR (the difference between peak and rest end-systolic pressure-volume ratio, ESPVR) ≥ 0.4 mmHg/mL/m2.
The prognostic stratification of patients was better with FFR, beyond the standard LV ejection fraction evaluation,
also in the particular settings of severe mitral regurgitation or diabetics without stress-induced ischemia. In the
particular setting of selection of heart transplant donors, the stress echo FFR was able to correctly select 34 marginal
donor hearts efficiently transplanted in emergency recipients. Starting in 2007, we introduced an operator-
independent cutaneous sensor to monitor the FFR: the force is quantified as the sensed pre-ejection myocardial
vibration amplitude. We demonstrated that the sensor-derived force changes at increasing heart rates are highly
related with both max dP/dt in animal models, and with the stress echo FFR in 220 humans, opening a new
window for pervasive cardiac heart failure monitoring in telemedicine systems.
Keywords: Force-frequency relation, Pressure-volume relation, Stress echo, Contractility, Heart failure, Wearable
contractility sensor, Molecular animation, BioblenderIntroduction
The assessment of left ventricular contractility (usually
obtained in the daily routine through gross proxies such
as ejection fraction and regional wall motion) is an old
dream for the cardiologist, but until recently it has also
been a methodological nightmare. The pressure-volume
relationship is a conceptually immaculate way to assess
contractility and is extensively used in the experimental
setting for animal studies, but only rarely in the clinical* Correspondence: bombardini@ifc.cnr.it
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article, unless otherwise stated.arena, and then only for research purposes in complex,
technically demanding studies requiring invasive cardiac
catheterization and maneuvers in the cath lab, with the at-
tending risks of invasivity, contrast injection and radiation
exposure. In the last 10 years, left ventricular contractility
was brought into the noninvasive stress imaging lab, and
particularly in the stress echo lab, where with minimal
extra-computing time and virtually no extra-imaging time,
left ventricular contractility can be measured at baseline
and during stress with simple raw measurements of end-
systolic pressure (by tonometry or cuff sphygmomanom-
eter) and end-systolic volume (by 2D or, even better, realntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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no longer “cuts the airy way” of pathophysiology but has
entered the real world of clinical cardiology. This review
will discuss the pathophysiological basis, experimental evi-
dence, and clinical data supporting a more extensive use
of contractile reserve in key diagnostic domains such as
identification of coronary artery stenosis, myocardial via-
bility and initial occult cardiomyopathy.
The pathophysiological basis
Contractility is the intrinsic ability of heart muscle to gen-
erate force and to shorten, independently of changes in the
preload or afterload with fixed heart rates. At the molecu-
lar level the crux of the contractile process lies in the chan-
ging concentrations of Ca2+ ions in the myocardial cytosol.
Ca2+ ions enter through the calcium channel that opens in
response to the wave of depolarization that travels along
the sarcolemma. These Ca2+ ions “trigger” the release of
more calcium from the sarcoplasmic reticulum (SR) and
thereby initiate a contraction-relaxation cycle [1]. An in-
creased stimulation rate increases the force of contraction:
the explanation is repetitive Ca2+ entry with each de-
polarization, and hence, an accumulation of cytosolic cal-
cium. As the heart fails, there is a change in the gene
expression from the normal adult pattern to that of fetal
life with an inversion of the normal positive slope of the
force-frequency relation [2]: systolic calcium release and
diastolic calcium reuptake process is lowered at the basal
state, and instead of accelerating for increasing heart rates,Figure 1 The 150-year-long journey of myocardial contractility from b
techniques, and from imaging-dependent to imaging-independent asslows down [3] (Additional files 1, 2, 3, 4, 5). In the past,
several attempts were made to transfer the pure physio-
logical concept of contractility, expressed in the isolated
myocardial fiber by the maximal velocity of contraction of
unloaded muscle fiber (Vmax), to the in vivo beating heart.
Suga and Sagawa achieved this aim by measuring pres-
sure/volume loops in the intact heart: during a positive
inotropic intervention, the pressure volume loop reflects a
smaller end-systolic volume and a higher end-systolic pres-
sure [4] (Figure 1). The pressure-volume relationship is the
most reliable index for assessing myocardial contractility
in the intact circulation and is almost insensitive to
changes in preload and afterload. Non-invasive measure-
ment of the end-systolic pressure-volume-ratio (ESPVR)
for increasing heart rates during stress in the echo is the
practical answer to this new clinical demand due to a
current dramatic increase in the number of heart failure
patients [5]. Ten years ago ΔESPVR (or simpler PVR,
pressure-volume relation) was introduced in the stress
echo lab as a measure of the heart rate-dependent changes
in contractility [6], associated or not with adrenergic
stimulation [7,8] (Figure 2).
The stress echo methodology
The evaluation of LV contractility is potentially amenable
to non-invasive assessment in the cardiac imaging lab,
since cuff systolic pressure is a proxy of end-systolic pres-
sure (in absence of aortic stenosis) and end-systolic vol-
umes can be evaluated by radionuclide ventriculographyench to bedside, from catheterization lab to cardiac imaging
sessment.
Figure 2 FFR, from myocardial strips to the echo lab. Isolated cardiomyocytes (upper panel): upregulation of Ca2+ entry through Ca2+
channels by high rates of beating is involved in the frequency-dependent regulation of contractility. The effect of increasing contractility by
increasing heart rate ("pure" Bowditch treppe) is intrinsic to myocardium and takes a few seconds to occur, while the β-adrenergic amplification
of the force-frequency relation (FFR) takes longer, i.e., 30–40 seconds, the time it takes for β-receptor activation and cAMP synthesis (on the right:
FFR + ISO). (Modified from: Piot C, Circ 1996 [3]). Middle panel: measurements of twitch tension in isolated left-ventricular strips from explanted
cardiomyopathic hearts: the FFR of these failing groups both exhibit a negative treppe at contraction frequencies above about 100 bpm. The
contraction frequency at which the FFR begins its descending limb ("optimum stimulation frequency") declines progressively in the order: ASD
(atrial septal defect), CAD (coronary artery disease), IDDM (diabetic myopathy), MR (mitral regurgitation), DCM (dilated cardiomyopathy). (Modified
from: Mulieri LA. R.A. Howarth Ed. 1997). Lower panel: time sequence during stress echo; the force-frequency relation is built off line. The
force-frequency relation is defined as up-sloping when the peak stress systolic pressure/end-systolic volume index (SP/ESV index) is higher than
baseline and intermediate stress values; biphasic, with an initial up-sloping followed by a later down-sloping trend, when the peak stress SP/ESV
index is lower than intermediate stress values; flat or negative, when the peak stress SP/ESV index is equal to or lower than baseline stress values.
The critical heart rate (or optimum stimulation frequency) is the human counterpart of the treppe phenomenon in isolated myocardial strips
(Modified from Bombardini T, CU 2005 [1]).
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2D-echo, both at baseline and during stress. To build the
force-frequency relation, the force is determined at each
step as the ratio of the systolic pressure (cuff sphygmo-
manometer)/end-systolic volume index (biplane Simpson
rule/body surface area) (Additional files 6 and 7). The LV
end-systolic volume is obtained from apical four-chamber
and two-chamber view using the biplane Simpson method
[6-8]. The LV end-systolic volume is assessed at rest andat peak stress and normalized by dividing it by body sur-
face area. Only representative cycles with optimal endo-
cardial visualization are measured and the average of three
measurements are taken. The endocardial border is traced,
excluding the papillary muscles. The frame with the smal-
lest left ventricular cavity is considered to be the end-
systolic frame. The Left Ventricular End-Systolic Pressure
(LVESP, mmHg) is obtained as LVESP = 0.9 * Systolic
Blood Pressure (mmHg) [10]. The end-systolic pressure-
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tio of the end-systolic pressure [ESP] to the LV end-systolic
volume indexed for body surface area. The ESPVR is deter-
mined at rest and at peak stress. The ΔESPVR (or simpler
PVR, pressure-volume relation) is calculated as the variation
between rest and peak stress ESPVR. The rest ESPVR, the
peak stress ESPVR and the ΔESPVR are built offline
[6-8,11]. The force-frequency relation is defined as up-
sloping when peak stress ESPVR is higher than baseline and
intermediate stress values (Figure 3 upper panel); biphasic,
with an initial up-sloping followed by a later down-sloping
trend, when peak stress ESPVR is lower than intermediate
stress values [12,13] (Figure 3 middle panel), flat or negative,
when peak stress ESPVR is equal to or lower than baseline
stress values (Figure 3 lower panel). The conventionallyFigure 3 Methodology of the force-frequency relation with stress ech
sphygmomanometer (first row); LV end-systolic volumes (ESV) calculated w
m.) during dobutamine infusion (third row); in the lowest row, the force-fre
(second column), and at different steps (third, fourth, fifth columns) up to p
rate is accompanied by an increased systolic pressure with smaller end-systol
% = 32%) without dilation, no stress-induced ischemia. The PVR was biphasic,
critical heart rate (90 b.p.m.) was the heart rate beyond which SP/ESV index d
symptoms (dyspnea). (C) A subject with post-MI depressed baseline LV functi
by no changes in end-systolic volumes (abnormal flat PVR). (Modified from Gr
PVR = Pressure-volume relation; SP = Systolic pressure; SP/ESV = Systolic pressuused stimuli in stress echocardiography act via different
mechanisms to detect myocardial contractility [14]: exercise
acts via heart rate increase and endogenous catecholamine
stimulation during exercise [6] (Additional files 6 and 7);
dobutamine acts via heart rate increase and exogenous ad-
renergic stimulation [7]; pacemaker stress is applied in pa-
tients with permanent PM: external programming of the
permanent PM induces a controlled change in heart rate,
with no adrenergic stimulation [8]. Dipyridamole stress
causes a three- to fourfold increase in coronary blood flow
and increases contractile function by the Gregg effect [11].
Feasibility and clinical applications
Starting in 2003 we introduced the FFR measurement in
the stress echo lab using the ESPVR (the Suga index) ato. Left, from upper to lower rows: systolic blood pressure (SP) by cuff
ith the biplane Simpson method (second row); heart rate increase (b.p.
quency relation built off-line with the values recorded at baseline
eak exercise (seventh column). (A) Normal subject. An increased heart
ic volumes (normal up-sloping PVR). (B) A subject with LV dysfunction (EF
with an initial up-sloping followed by a later down-sloping trend, the
eclined by 5%. The test was stopped at 20 gammas due to limiting
on (EF%= 30%). An increased heart rate at peak exercise is accompanied
osu A, EHJ 2005). BSA = Body surface area; ESV = End-systolic volume;
re/end-systolic volume ratio.
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patients in peer-reviewed journals: 483 with exercise
stress, 34 with pacing stress, 850 with dobutamine stress
echo, 664 with dipyridamole stress echo [6-8,11,15-27].
The feasibility and the reproducibility of measurements
was consistently reported as very high in all studies, with
all forms of stresses, and in different patient populations –
from ischemic or idiopathic dilated cardiomyopathy to
severe mitral insufficiency (Table 1). We did not study pa-
tients with aortic stenosis. Exercise stress echocardiog-
raphy is strictly contraindicated in symptomatic patients.
In asymptomatic patients with aortic stenosis the ΔESPVR
could be calculated during stress, but the trans aortic sys-
tolic pressure drop should be added to the brachial systolic
pressure to correctly calculate the ESPVR both at rest and
at peak stress. Different normal vs abnormal ΔESPVR cut-
off-values have been observed for different stressors such
as exercise [6,15,18,23,25,27,28], subclinical heart disease
in diabetes [19,28], to donor hearts not eligible for heart
transplant [17,26,29]. A systematic review of the literature
with meta-analysis was needed to identify all published pa-
pers examining the use of ΔESPVR (PVR) for the predic-
tion of cardiac death and/or heart failure hospitalization in
patients with resting LV dysfunction. In eight studies sum-
marized in Table 2, the prognostic information was avail-
able, enrolling patients with left ventricular dysfunction
and non-inducible ischemia at stress echocardiography
with different selection criteria – from suspected coronary
artery disease to dilated cardiomyopathy. The optimal cut-
off for prognostically relevant events was different with
the different stresses, the different populations, and the
different prognostic end-points taken into consideration
(Table 3). In particular, we identified six [7,8,15,23-25] eli-
gible studies which provide information on the incidence
of cardiac death and/or heart failure hospitalization in
heart failure patients. During a median follow-up of
19 months (interquartile range 6–48), 53 deaths (49 car-
diac, 4 non-cardiac), and 83 HF-related hospitalizations
occurred. Of the 83 patients with hospitalizations for heart
failure, 5 underwent heart transplant, and 20 a CRT-ICD
implant. Eighteen patients underwent revascularization at
follow-up (5 with viability response). With a receiver-
operating characteristic analysis, ΔESPVR < 0.4 mmHg/
ml/m2 (area under the curve 0.758, 95% CI 0.708 to 0.803;
positive predictive value 55%, negative predictive value
84%), was the best predictor of future primary cardiovas-
cular events (composite of overall death and heart failure
hospitalization) (Figure 4). Resting LVEF, a powerful pre-
dictor of future cardiovascular events, showed a significant
cutoff value of < 30% (area under the curve 0.730, 95% CI
0.680-0.780; positive predictive value 50%, negative pre-
dictive value 81%). A viability response (WMSI decrease
during stress) showed a trend toward prediction of cardiac
events with a significant cutoff value of −0.235 (AUC0.567, 95% CI 0.507 to 0.627; positive predictive value
42%, negative predictive value 72%). The same contractile
reserve cutoff (ΔESPVR < 0.4 mmHg/mL/m2 ) was also ef-
fective in stratifying the risk in the subgroups with pro-
gressively more severe baseline dysfunction (Figure 5), and
in the subgroups with different stimuli used in stress echo-
cardiography (Figure 6).
Contractile reserve and coronary flow reserve
In patients with normal baseline left ventricular function
and negative stress echo by standard wall motion criteria,
the evaluation of contractile reserve provided additional
diagnostic information. Lack of contractile reserve can
identify minor forms of anatomically significant coronary
artery disease (CAD) that are unable to give the absolute
subendocardial underperfusion necessary to induce true
regional ischemia and wall motion abnormalities. In pa-
tients with negative stress and significant (≥ 50%) ob-
structive CAD, the contractile reserve is attenuated in
proportion to the severity of stenosis [11]. A negative con-
tractile reserve, especially when combined with reduced
coronary flow reserve (CFR), predicts angiographic evi-
dence of coronary stenosis in patients with normal LV
function and negative (not normal!) dipyridamole stress
echocardiograms. In patients with DCM and microvascu-
lar dysfunction, the CFR was directly related to the con-
tractile reserve; global heart function is increased after a
vasodilator stimulus due to the erectile properties of nor-
mal myocardium.
Contractile reserve, strain and strain rate
Galderisi et al. [30] assessed strain rate (SR) imaging
during dobutamine stress, to investigate inotropic re-
sponse in patients with type 2 diabetes mellitus and
without coronary artery disease. At every level of dobu-
tamine, strain increased with increasing heart rate (HR)
in either group (both P < .0001), but the slope of the
overall relation between HR and strain was lower in dia-
betics (b = −0.08) than in controls (b = −0.14) (P < .01).
The blunted slope of the relation between HR and re-
gional strain suggests the impairment of the myocardial
force-frequency relation, indicating altered contractile
reserve in uncomplicated diabetes.
In an another paper by Jellis et al. [28], in subclinical
diabetic heart disease the ΔESPVR is relatively poorly as-
sociated with standard echocardiographic measures of
myocardial dysfunction such as calibrated integrated back-
scatter, strain, and strain rate. The disparity between the
ΔESPVR and echocardiographic parameters of myocardial
dysfunction is likely because individual markers of LV dys-
function identify different pathological processes occur-
ring concurrently within the spectrum of diabetic heart
disease. These processes may include interstitial fibrosis,
microvascular disease and cardiac autonomic neuropathy;
Table 1 The spectrum of diagnostic applications of contractility in the stress echo lab












EX 50 Consecutive pts 100%
(by selection)
NA NA Biphasic PVR (<2 mmHg/ml/m2)
with contractility loss at ischemia
Grosu, Eur
Heart J 2005 [7]








Biphasic PVR (<2 mmHg/ml/m2)
with contractility loss at ischemia
Bombardini,
Eur J Heart Fail
2005 [8]
Pacing 26 Permanent PM 100%
(by selection)
NA NA Biphasic PVR (<2 mmHg/ml/m2)
with contractility loss at ischemia
Bombardini, Int J
Cardiol 2013 [8]














88% NA NA Flat PVR (< 0.4 mmHg/ml/m2)
in increased myocyte diameter
Cortigiani,
Heart 2009 [19]
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EX 63 Normal LV
function in
severe MR
100% 5% 4% Blunted PVR (< 2.1 mmHg/ml/m2)




















DIP 18 Older donor
hearts
100% NA NA CAD / myocardial disease of non
transplanted hearts with abnormal
negative (< 0 mmHg/ml/m2) PVR
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Table 1 The spectrum of diagnostic applications of contractility in the stress echo lab (Continued)
Bombardini,
JASE 2011 [17]
DIP 39 Older donor
hearts
100% NA NA Normal coronary arteries and post-
TX LV function in 19 hearts with
up-sloping (> 0 mmHg/ml/m2) PVR
Bombardini, CU
2103 [29]
DIP 6 Stunned donor
hearts
100% NA NA TX of hearts with viability response
and positive (> 0 mmHg/ml/m2) PVR
CAD = Coronary artery disease; CHF = Chronic heart failure; DC = Dilated ischemic cardiomyopathy; DCM = Idiopathic dilated cardiomyopathy; DIP = Dipyridamole;
DOB = Dobutamine; EX = Exercise; LV = Left ventricle; MR =Mitral regurgitation; NA = Not available; PM = Pace-maker; PVR = Pressure-volume relation; TX = Heart
transplant. *Both for intraobserver and interobserver analysis, > 95% of the differences were between d −2 SD and d +2 SD, as described by Bland and Altman.
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the disease process.
Limitations
Limitations of this noninvasive study include that peak cuff
systolic pressure was used as a surrogate marker of end-
systolic pressure. However, there is a close relationship
between these two variables, and any sampling error is
duplicated between rest and stress values, thereby not af-
fecting the overall ratio [28]. Calcium channel blockers and
β-blockers were not withdrawn before testing in 227 (57%)
of patients, and there may still have been blunting of the
systolic blood pressure. However, in this “real world” study
this was unavoidable as it was thought to be unethical to
withhold proven medical therapy from subjects.
Future developments: imaging-independent, sensor-
based contractility
In recent years, the FFR has been transferred from the ex-
perimental lab to the clinical arena, and in particularTable 2 The prognostic value of contractility in the stress ech
Author, year Stress Pts (n) Inclusion criteria LVEF Median
up (m
Grosu A et al.,
2005 [7]
DOB 95 Medically treated pts
with LV dysfunction
40±15% 1
Otasevic P et al.,
2006 [20]




et al., 2008 [15]
EX 99 Medically treated pts
with negative stress
47±14% 2
Agricola E et al.,
2008 [23]
EX 37 Functional MR in
LV dysfunction
29±7% 2
Ciampi Q et al.,
2010 [24]




et al., 2011 [17]




et al., 2013 [25]
EX 172 Followed-up Pts
with negative stress
53±14% 3
DIP 482 50±17% 2
DOB 237 39±15% 6
Cortigiani L
et al., 2009 [19]
DOB 233 Diabetics with
negative stress
52±10% 1
CABG = Coronary artery by-pass grafting; CAD = Coronary artery disease; CRT = Card
EX = Exercise; HF = Heart failure; LV = Left ventricle; LVEF = Left ventricular ejection f
PCI = Percutaneous coronary intervention; PPV = Positive predictive value; PVR = Prewithin the clinical arena from the cardiac catheterization
to the stress echo lab, with an obvious step-up in inter-
est and applicability. Ideally, the non-invasive, imaging-
independent, objective assessment of FFR would greatly
further enhance its practical appeal (Figure 1). A new cu-
taneous force-frequency relation recording system has re-
cently been validated in the stress echo lab, based on heart
sound amplitude and timing variations at increasing heart
rates [16]. Force-frequency relation recording is feasible
with a single precordial vibration sensor connected to a
standard ECG monitoring electrode, and quantitatively
documents left ventricular contractility changes in a totally
automatic, operator-independent fashion. Sensor built
force-frequency relation is strictly related to the standard
stress echo built FFR. Echocardiography uses artificially
generated cardiac reflections. The isovolumic systolic force
sensor simply records naturally generated heart vibrations.
The FFR is built online. The system is portable, and the re-
mote transmission of the FFR slope and shape is feasible










8 <0.2 mmHg/ml/m2 Death, HF 18 (19%) 77% 89%
0 <0.33 mmHg/ml/m2 Death 27 (46%) 62% 84%
1 <2.2 mmHg/ml/m2 Death, HF, ↑NYHA 29 (29%) 62% 98%
0 <0.4 mmHg/ml/m2 Death 8 (22%) 35% 93%
2 <0.7 mmHg/ml/m2 Death, HF 22 (31%) 40% 91%
4 <0 mmHg/ml/m2 Death 2 (13%) 50% 94%
2 <1.34 mmHg/ml/m2 Death, HF 29 55% 96%
1 <0.46 mmHg/ml/m2 Death, HF 68 24% 97%
<0.56 mmHg/ml/m2 Death, HF 37 40% 94%
8 <12 mmHg/ml/m2 Death, PCI/CABG 62 (27%) 36% 83%
iac resynchronization therapy; DIP = Dipyridamole; DOB = Dobutamine;
raction; MR =Mitral regurgitation; NPV = Negative predictive value;
ssure-volume relation.
Table 3 PVR cut-off for different targets
Author, year Stress PVR cutoff (mmHg/mL/m2) Clinical target
Bombardini et al., JASE 2003 [6] EX <4.7 Patients vs normal
Agricola et al., Am J Cardiol 2005 [18] EX < 2.1 Pulmonary hypertension in MR
Bombardini et al., Int J Cardiol 2008 [15] EX < 2.2 Prognosis in negative stress
Agricola et al., Int J Cardiol 2008 [23] EX < 0.4 Prognosis in MR in DCM/DC
Jellis et al., Circ Cl 2010 [28] EX ≤ 12 Subclinical heart disease in diabetic type 2
Grosu et al., Eur Heart J 2005 [7] DOB < 0.2 Prognosis in DCM/DC
Otasevic et al., Heart 2006 [20] DOB < 0.4 Prognosis in DCM
Ciampi et al., JASE 2010 [22] DOB > 1.4 Exercise tolerance in CHF
Ciampi et al., Am Heart J 2010 [24] DOB > 0.7 CRT responders
Otasevic et al., Eur J Heart Fail 2005 [21] DIP < 0.6 Prognosis in DCM
Bombardini et al., JASE 2011 [17] DIP ≤ 0 Subclinical heart disease in heart donors
Bombardini et al., Eur J Heart Fail 2005 [8] PM < 2.5 Patients vs normal
CHF = Chronic heart failure; CRT = Cardiac resynchronization therapy; DC = Dilated ischemic cardiomyopathy; DCM = Idiopathic dilated cardiomyopathy; DIP =
Dipyridamole; DOB = Dobutamine; EX = Exercise; MR =Mitral regurgitation; PM = Pace-maker; PVR = Pressure-volume relation.
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in home monitoring systems. To fully establish the advan-
tages and limits of this new method, comparisons with left
ventricular pressure-volume loops in humans and multi-
center study data are needed.
Conclusions
Patients with abnormal rest LVEF and negative stress
echocardiography by conventional regional wall motion
criteria may still experience an adverse outcome in the
long-term follow-up, which can be identified by ΔESPVR,
providing a prognostic stratification in addition to that
given by regional wall motion abnormalities and LVEF.Figure 4 Prognostic predictors – Left panel. Kaplan-Meier survival curve
medically treated patients stratified according to the presence of stress ΔL
curves (considering combined death or HF hospitalization as an endpoint)
stress ΔESPVR ≥ 0.4 mmHg/mL/m2 vs rest as cut-off value.Despite exercise, pharmacological and pacing are different
ischemic stressors in terms of cardiac, systemic and coron-
ary hemodynamics, the same contractile reserve cut-off
value of ΔESPVR stratifies patients equally well for non-
ischemic events at follow-up. In this task, the contractility
information complements clinical, coronary flow reserve
(CFR), and therapeutic information, allowing stratification
of the different “shades of white” of a negative response,
with very benign prognosis in subjects with normal resting
function, preserved resting LV function, normal (> 2.0)
CFR on LAD, and normal test studied off-therapy, with
hard events rate < 1% per year. At the other end of the
spectrum are subjects with subclinical tests, undergoings (considering combined death or HF hospitalization as an endpoint) in
VEF ≥ 5% vs rest as cut-off value. Right panel. Kaplan-Meier survival
in medically treated patients stratified according to the presence of
Figure 5 Survival in patients with negative stress echo and different rest LV dysfunction. Kaplan-Meier survival curves (considering
combined death or HF hospitalization as an endpoint) in medically treated patients stratified according to the presence of stress end-systolic
pressure-volume relation-based contractile reserve (ΔESPVR ≥ 0.4 mmHg/mL/m2 vs rest as cut-off value) in patient with moderate (left panel),
severe (middle panel), or extreme (right panel) rest LV dysfunction.
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tractile reserve, reduced CFR and hard-event rate > 3%
(Table 4). Contractility assessment may be one of the pa-
rameters useful for assessing “wolves in sheep’s clothing” –
patients with suboptimal prognosis in spite of negative
stress echo by wall motion criteria. On the basis of avail-
able, still largely immature but growing evidence, the as-
sessment of contractile reserve with ΔESPVR might
provide clinically incremental information in three main
subsets: 1) patients with known or suspected coronary ar-
tery disease with test negativity by regional wall motionFigure 6 Survival in patients with negative stress echo according to t
combined death or HF hospitalization as an endpoint) in medically treated
pressure-volume relation-based contractile reserve (ΔESPVR ≥ 0.4 mmHg/m
according to exercise stress echo. Middle panel, patients (n = 165) stratified
stratified according to dobutamine stress echo.analysis (in whom higher contractile reserve means better
prognosis, even in extreme conditions such as selection of
potential aged heart donors); 2) patients with ischemic or
non-ischemic left ventricular dysfunction without func-
tional recovery with regional or global wall motion ana-
lysis, in whom higher contractile reserve means better
prognosis; 3) patients with valvular heart disease (for in-
stance, asymptomatic severe mitral insufficiency) or initial
cardiomyopathy (for instance in diabetics, hypertensives
or oncology patients undergoing potentially cardio-toxic
chemotherapy), in whom the detection of initial, occult,he employed stress. Kaplan-Meier survival curves (considering
patients stratified according to the presence of stress end-systolic
L/m2 vs rest as cutoff value). Left panel, patients (n = 57) stratified
according to dipyridamole stress echo. Right panel, patients (n = 160)
Table 4 Negative stress echo by wall motion criteria:
further prognostic refinement
RISK Not-so-low Very low
Dose/load Submaximal Maximal
Resting ejection fraction <40% >50%
Anti-ischemic therapy + -
Coronary flow reserve (ratio) <2.0 >2.0
Contractile reserve (ΔESPVR, mmHg/mL/m2) <0.4 >0.4
Hard events/year >3% <1%
ΔESPVR (or simpler PVR, pressure-volume relation): the difference between
peak stress and rest ESPVR.
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tion can be important when conventional parameters of
left ventricular function (such as regional wall motion or
ejection fraction) look normal during stress. The long 150-
year journey of myocardial contractility from the physi-
ology lab to bedside is over. The clinical adventure begins
now, and cardiologists should make the most of the clin-
ical dividends promised by this fascinating variable.
Additional files
Additional file 1: Dilated Cardiomyopathy: A molecular view.
Dilated Cardiomyopathy is a common heart disease that causes heart
myofibers to pulse in a weakened way, which becomes particularly
dangerous under stress, when heartbeat is accelerated. (The full quality
video can be accessed at this link: https://vimeo.com/79085937).
Additional file 2: Dilated Cardiomyopathy: The sarcomere At each
cycle of heartbeat, the heart cell contracts (shortens) at systole and
relaxes at diastole. Under stress, both the speed and the intensity of
the movement are increased. In the DCM heart, both the structure and
the activity are impaired: the mitochondrion is enlarged, due to the
excess ATP request, and the fibers are not as compact and aligned as in
the healthy fiber. The relaxation phase is never complete, resulting in the
typical ECG track. Under stress the situation is worsened: the heart fibers,
unable to completely de-contract, try to compensate by even stronger
contraction, in a forward loop that worsens with time, and can lead to
heart failure. (The full quality video can be accessed at this link: https://
vimeo.com/79085938).
Additional file 3: Dilated Cardiomyopathy: Ca2+ induced Ca2+
release (zoom to synaptic junction). The signal to initiate contraction
is a brief depolarization of the membrane, which triggers a very rapid
release of calcium from the sarcolemma. This is followed by more
sustained release of Ca2+ from the ryanodine receptor on the T Tubules.
In this way, the signal rapidly diffuses throughout the contractile fiber.
When more blood is needed in the organism, the frequency of signal is
increased, and more Ca2+ is released. However, all Ca2+ is removed from
the fiber before the onset of next beat. The DCM heart is impaired in the
re-uptake of Ca2+, resulting in a small amount of Calcium constantly
present in the fiber. When more CA2+ is released because of higher de-
mand, the problem of re-uptake worsens. (The full quality video can be
accessed at this link: https://vimeo.com/79085979).
Additional file 4: Dilated Cardiomyopathy: Actin-myosin contraction.
Contraction is the result a sliding of actin and myosin fibers, due to the
activity of the myosin cycle: this cycle is active in the presence of
Calcium, which mediates transmission of signal to both the actin and
myosin fibers, via other accessory proteins. The activity requires energy, in
the form of ATP (not shown). When Calcium has been removed, the
myosin heads detach from the actin fibers and the muscle can relax. In the
DCM heart calcium re-uptake is incomplete: this leads to a constantcontraction which, on one hand requires more energy (hence the
enlarged mitochondria) and on the other impedes full extension of the
heart fibers during relaxation, thus limiting the amount of incoming blood.
The problem is even worse under stress conditions. Note that due to the ex-
cess work and the lack of total relaxation, the actin and myosin fibers of the
dilated heart are not regularly aligned and the overall
structure of the myofiber is slightly disorganized. (The full quality video can
be accessed at this link: https://vimeo.com/79085977).
Additional file 5: Dilated Cardiomyopathy: Calcium re-uptake.
Clearing of intracellular Calcium is carried out by the Sarcoplasmic
Reticulum Calcium Pump (known as SERCA), a very efficient protein
capable of concentrating Calcium at a rate of two ions for one ATP. One
of the molecular defects of the dilated heart is the reduced efficiency of
this pump: this is physiologically counterbalanced by a higher expression
(and more intense activation) of the Na+/Ca2+ exchanger of the plasma
membrane. The problem is especially felt under stress: in this condition,
with faster cycles, even more Calcium is released, aggravating the burden
of re-uptake on the defective SERCA, not well-complemented by the
activity of the plasma membrane exchanger. Since this pump is also
inefficient, the final result is that blood circulation is not sustained to the
required level. (The full quality video can be accessed at this link: https://
vimeo.com/79085978).
Additional file 6: Force-frequency curve with stress echo in a
normal subject. Upper panel: On the left, systolic blood pressure by cuff
sphygmomanometer (SP, first row); left ventricular end-systolic volumes
calculated with biplane Simpson method (ESV, second row); heart rate
increase during stress (bpm, third row); in the lowest row, the force-
frequency curve built off-line with the values recorded at baseline
(second column), and at different steps (third, fourth, fifth column) up to
peak stress (sixth column). An increased heart rate is accompanied by an
increased systolic pressure with smaller end-systolic volumes (normal up
sloping force-frequency relation).
Additional file 7: Force-frequency curve with stress echo in a
subject with dilated cardiomyopathy and depressed baseline left
ventricular function (EF% = 30%). On the left: systolic blood pressure
by cuff sphygmomanometer (SP, first row); left ventricular end-systolic
volumes calculated with biplane Simpson method (ESV, second row);
heart rate increase during stress (bpm, third row); in the lowest row, the
force-frequency relation built off-line with the values recorded at baseline
(second column), and at different steps (third, fourth, fifth column) up to
peak stress (sixth column). An increased heart rate at peak exercise is
accompanied by no changes in end-systolic volumes (abnormal flat
force-frequency relation).
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